LGT Group Foundation Makes New $293,000 Investment in Haleon plc (NYSE:HLN)

LGT Group Foundation bought a new stake in Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 30,711 shares of the company's stock, valued at approximately $293,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HLN. Sierra Ocean LLC acquired a new stake in shares of Haleon during the fourth quarter worth $26,000. Versant Capital Management Inc lifted its position in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock worth $34,000 after buying an additional 3,348 shares during the period. Geneos Wealth Management Inc. acquired a new stake in Haleon in the 4th quarter worth about $35,000. Toronto Dominion Bank boosted its stake in Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock worth $38,000 after buying an additional 3,470 shares during the last quarter. Finally, Spire Wealth Management purchased a new stake in Haleon in the 4th quarter valued at about $39,000. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on HLN. HSBC reiterated a "hold" rating on shares of Haleon in a report on Wednesday. Sanford C. Bernstein downgraded shares of Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Finally, Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Five research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $10.95.

Remove Ads

Haleon Trading Up 0.5 %

NYSE HLN traded up $0.06 during mid-day trading on Friday, hitting $10.45. The company's stock had a trading volume of 10,381,006 shares, compared to its average volume of 6,535,003. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80. The stock's fifty day simple moving average is $9.66 and its two-hundred day simple moving average is $9.86. The firm has a market capitalization of $47.29 billion, a P/E ratio of 30.72, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25.

Haleon (NYSE:HLN - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Research analysts expect that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The business also recently announced a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be given a $0.1166 dividend. This is an increase from Haleon's previous -- dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon's dividend payout ratio is presently 58.97%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.